Extendicare (TSE:EXE) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says

Extendicare (TSE:EXE) had its price objective hoisted by Royal Bank of Canada from C$9.50 to C$11.00 in a research note issued on Thursday,BayStreet.CA reports. The firm presently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 4.46% from the company’s current price.

Separately, TD Securities lifted their price target on Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a research report on Thursday, November 14th.

Extendicare Stock Down 0.1 %

Shares of EXE traded down C$0.01 during trading hours on Thursday, hitting C$10.53. The company had a trading volume of 99,403 shares, compared to its average volume of 135,117. The firm has a fifty day moving average price of C$9.47 and a 200-day moving average price of C$8.31. The company has a debt-to-equity ratio of 305.80, a quick ratio of 0.98 and a current ratio of 0.60. The stock has a market capitalization of C$878.94 million, a price-to-earnings ratio of 15.51 and a beta of 1.26. Extendicare has a 52-week low of C$6.63 and a 52-week high of C$10.64.

Extendicare Company Profile

Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.